You are here

Home Publications

Publications

Combine Filters and Search to find Publications more quickly

Pricing Framework for Australian Public Hospital Services 2022–23

1 December 2021

The Pricing Framework for Australian Public Hospital Services 2022–23 (the Pricing Framework) is the key strategic document underpinning the national efficient price and national efficient cost for the 2022–23 financial year.

Chimeric antigen receptor T cell therapy (CAR-T cell): guidelines for costing, counting and reconciliation of funding

18 June 2020

The guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults (up to 25 years) with Acute Lymphoblastic Leukaemia (ALL) who relapse or do not respond to initial therapy.